L evofloxacin is a third-generation, strictly synthetic flouroquinolone antibiotic. It has bactericidal activity against a wide variety of bacteria that are gram positive (G+ve) and gram negative (G-ve) (Al-Soufi and Al-Rek-abi, 2019). The principal target of quinolones is DNA gyrase, an essential bacterial enzyme (Abdel-Alim et al., 2017). Several studies have recorded that the most common serious effects associated with fluoroquinolones are headache, diarrhea, oxidative stress, hemolytic anemia, liver and kidney cellular damages (Owens and Ambrose, 2005;